AUSTRALIAN-BORN Luke Miels has been named as the new president, global pharmaceuticals for GlaxoSmithKline.
Miels joins GSK from his current role as executive vice president of AstraZeneca in Europe.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jan 17